Scientists discover genetic variants that speed up and slow down brain aging
The findings could provide potential targets for new Alzheimer’s drugs.
Study finds some of the world’s lowest dementia rates in Amazonian indigenous groups
Research adds to evidence that healthier pre-industrial lifestyles may hold clues to preventing Alzheimer’s and other dementias.
USC endocrinologist takes Alzheimer’s disease research in new directions
By studying the APOE4 gene and its impact on brain inflammation and metabolism of fatty acids, Hussein Yassine discovers potential new ways to prevent cognitive decline.
A brother’s struggle inspires new Alzheimer’s and dementia research collaboration
After watching his twin brother lose a 15-year fight with the memory-robbing illness, Dan Epstein decided to do something about it. The result: an unprecedented research collaboration between USC and UC San Diego.
Study finds older Americans are largely unaware of new Alzheimer’s drug
Among older Americans surveyed in the weeks after FDA approval of aducanumab, few could correctly answer true or false questions about the first new Alzheimer’s drug in decades.
With a $50 million gift, USC and UC San Diego join forces in Alzheimer’s research
A transformative donation from the Epstein Family Foundation will accelerate Alzheimer’s research at the two universities in a push to find better treatments and a cure.
In USC labs, another year of groundbreaking discoveries
Year in review: Whether they’re working with patients, test tubes or massive databases, USC scientists continue to push the envelope with discoveries that are literally changing people’s lives.
Stroke drug shows promise in treating Alzheimer’s and dementia
Mouse study of human stroke medication reveals potential defense against Alzheimer’s disease and other forms of dementia.
How does air pollution influence Alzheimer’s risk?
Studying neural stem cells could shed light on how environmental aspects interact with genetic risk factors for dementia, says University Professor Caleb Finch.
Medications, milestones and disease management: Q&A with Alzheimer’s researcher Lon Schneider
The psychiatry and neuroscience chair at the Keck School of Medicine of USC and director of the California Alzheimer’s Disease Center at USC discusses the role of medication in Alzheimer’s treatment.
USC studies show that clean air matters for a healthy brain
Researchers say their studies on air pollution and cognitive decline — one involving humans and one with mice — provide evidence that cleaner air may reduce risk for Alzheimer’s and other dementias.
Supporting the invisible, unpaid army of Alzheimer’s caregivers
More assistance is needed for the estimated 11 million people caring for loved ones with dementia, USC experts say.
Federal funding for Alzheimer’s multiplies at USC
More than 90 federal grants totaling $92 million were awarded to USC researchers in 2020, underscoring the university’s status as one of the nation’s leading research centers as we acknowledge World Alzheimer’s Day 2021.
Study ties air pollution to disparities in Alzheimer’s risk
Fine particle pollution may be one reason why Black women have double the risk of developing Alzheimer’s than white women, new research from the Keck School of Medicine of USC suggests.
7 tips about Alzheimer’s and brain health, from reducing risk to supporting caregivers
Experts from the USC Leonard Davis School of Gerontology share what they’ve learned from years of studying Alzheimer’s disease.
USC researchers share discoveries on Alzheimer’s disease and discuss strategies to fight the illness
A newly approved yet controversial drug, in particular, brings both hope and challenges for patients and clinicians.
Newly revealed potential treatment target for Alzheimer’s could help with late-stage disease
A new USC study may have unlocked therapy options to slow cognitive impairment in people with the APOE4 gene, which has long been associated with Alzheimer’s disease.
Keck School of Medicine awarded $2 million to help identify if financial vulnerability is risk factor for Alzheimer’s
A grant from the National Institutes of Health will allow the Han Research Lab to study the link between financial decision-making and Alzheimer’s disease.
Five Surprising Ways Plants Can Keep You Healthy
You might find a hangover cure, protection against Alzheimer’s and much more in nature’s bounty.
Brain changes following traumatic brain injury share similarities with Alzheimer’s disease
Using MRIs and machine learning, USC researchers mapped comparable degenerative changes in both gray and white matter of the brain.
Potential Alzheimer’s disease treatments could lead to significant state Medicaid savings
New disease-modifying treatments would help Medicaid avoid paying $186 billion from 2021 to 2040, a new USC study has found.
Does air pollution increase women’s risk of dementia?
High levels of fine particle pollution are associated with brain shrinkage patterns common in Alzheimer’s disease, a USC study finds.
USC leads new artificial intelligence study of Alzheimer’s disease
A $17.8 million grant from the National Institutes of Health will fund an AI-powered study of genetic, imaging and cognitive data collected from Alzheimer’s patients.
New clinical trial will test deep brain stimulation as Alzheimer’s treatment
Keck Medicine of USC is now enrolling individuals in a phase 3 clinical trial that will implant electrodes into subjects’ brains to potentially stop the progression of the disease.